Cover Image

In silico and in vitro investigations of antihelmintic activities of selected approved drugs

<p>Objective: We investigated the binding affinities of some approved drugs to Ascaris suum Mitochondrial Rhodoquinol Fumarate Reductase (MRFR), an essential enzyme for ascaris survival, and the possibility of repurposing these drugs as antihelmintic agents using in silico molecular docking an...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christopher Arinze Agube (Author), Daniel Lotanna Ajaghaku (Author), Ikemefuna Chijioke Uzochukwu (Author)
Format:	Book
Published:	Archives of Community Medicine and Public Health - Peertechz Publications, 2020-11-27.
Subjects:	Research Article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The Widely Used Antihelmintic Drug Albendazole is a Potent Inducer of Loss of Heterozygosity
by: Luiza S. E. P. Will Castro, et al.
Published: (2021)

In Silico and In Vitro Investigation of Anti Helicobacter Activity of Selected Phytochemicals
by: Deniz Al Tawalbeh, et al.
Published: (2022)

Inhibition of oxidative stress and gastric emptying as additional mechanisms of antidiabetic activity of Newbouldia laevis
by: Ikechukwu Sonne Mbagwu, et al.
Published: (2021)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods
by: Tiziana Ginex, et al.
Published: (2021)

Dostarlimab: From preclinical investigation to drug approval and future directions
by: Carlo Maria Cicala, et al.
Published: (2023)

Anti-inflammatory activities of Sigesbeckia glabrescens Makino: combined in vitro and in silico investigations
by: Zhangfeng Zhong, et al.
Published: (2019)

In vitro and in vivo antioxidant potentials of Alchornea floribunda leaf extract, fractions and isolated bioactive compounds
by: Daniel Lotanna Ajaghaku, et al.
Published: (2017)

In Silico Study for Similar FDA Approved Drugs as Inhibitors of SARS-CoV-2 Spike and the Host Receptor Proteins
by: Israa Mohamed Shamkh, et al.
Published: (2021)

Inhibition of Pancreatic Lipase by Flavonoid Derivatives: In Vitro and In Silico Investigations
by: The-Huan Tran, et al.
Published: (2024)

Anti-inflammatory potential of Curcuma heyneana: An in vitro and in silico investigation
by: Melanny Ika Sulistyowaty, et al.
Published: (2024)

Detección de metabolitos secundarios en Ambrosia peruviana Willd y determinación de la actividad antibacteriana y antihelmíntica Secondary metabolite detection in Ambrosia peruviana Willd and determination of antibacterial and antihelmintic activity
by: María del Pilar Guauque, et al.
Published: (2010)

Computational determination of toxicity risks associated with a selection of approved drugs having demonstrated activity against COVID-19
by: Maral Aminpour, et al.
Published: (2021)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Mostafa, et al.
Published: (2020)

Investigating the Antituberculosis Activity of Selected Commercial Essential Oils and Identification of Active Constituents Using a Biochemometrics Approach and In Silico Modeling
by: Katyna J. Boussamba-Digombou, et al.
Published: (2022)

Drug Absorption Studies: In Situ, In Vitro and In Silico Models
Published: (2021)

In silico investigation on the probable macromolecular drug targets involved in the anti-schizophrenia activity of Nardostachys jatamansi
by: Foong Xi Wei, et al.
Published: (2022)

Antibacterial potentiality of antiulcer and antispasmodic drugs with selected antibiotics against methicillin resistant Staphylococcus aureus: In vitro and in silico studies
by: Krishnan Akilandeswari, et al.
Published: (2015)

In Vitro‐to‐In Vivo Extrapolation of Transporter Inhibition Data for Drugs Approved by the US Food and Drug Administration in 2018
by: Jingjing Yu, et al.
Published: (2020)

An In Vitro and In Silico Investigation about <i>Monteverdia ilicifolia</i> Activity against <i>Helicobacter pylori</i>
by: Mariana Nascimento de Paula, et al.
Published: (2022)

Alpha-glucosidase inhibitory activities of astilbin contained in Bauhinia strychnifolia Craib. stems: an investigation by in silico and in vitro studies
by: Komgrit Eawsakul, et al.
Published: (2023)

Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation
by: Lu W, et al.
Published: (2024)

ACE inhibitory peptides in standard and fermented deer velvet: an in silico and in vitro investigation
by: Stephen R. Haines, et al.
Published: (2019)

Clinical development time is shorter for new anticancer drugs approved via accelerated approval in the US or via conditional approval in the EU
by: Ebru Demirci, et al.
Published: (2023)

Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against <i>Onchocerca gutturosa</i> in Gambia
by: Suzanne Gokool, et al.
Published: (2024)

Overview of drugs approved by the FDA in 2022
by: D. V. Kurkin, et al.
Published: (2023)

New approved drugs for psoriatic arthritis
by: F.M. Perrotta, et al.
Published: (2016)

Several FDA-Approved Drugs Effectively Inhibit SARS-CoV-2 Infection in vitro
by: Hua-Long Xiong, et al.
Published: (2021)

Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches
by: Omima S. Mohammed, et al.
Published: (2023)

In vitro, in vivo and in silico antiulcer activity of ferulic acid
by: Ratika Umre, et al.
Published: (2018)

Aminoglycosides as potential inhibitors of SARS-CoV-2 main protease: an in silico drug repurposing study on FDA-approved antiviral and anti-infection agents
by: Mohammad Z. Ahmed, et al.
Published: (2021)

The Role of Regulator-Imposed Post-Approval Studies in Health Technology Assessments for Conditionally Approved Drugs
by: Rick A. Vreman, et al.
Published: (2022)

In Vitro Screening of a 1280 FDA-Approved Drugs Library against Multidrug-Resistant and Extensively Drug-Resistant Bacteria
by: Lucie Peyclit, et al.
Published: (2022)

Unveiling potent Schiff base derivatives with selective xanthine oxidase inhibition: In silico and in vitro approach
by: Fatna Bellahcene, et al.
Published: (2024)

Rethinking the Appraisal and Approval of Drugs for Fracture Prevention
by: Juan Erviti, et al.
Published: (2017)

Getting the Right Evidence After Drug Approval
by: Rick A. Vreman, et al.
Published: (2020)

An update on the novel and approved drugs for Alzheimer disease
by: Hassan Ahmad Alhazmi, et al.
Published: (2022)

FDA approved injection drug against schizophrenia
by: article Editorial
Published: (2023)

A multidisciplinary approach to the antioxidant and hepatoprotective activities of Arbutus pavarii Pampan fruit; in vitro and in Vivo biological evaluations, and in silico investigations
by: Fatma A. Elshibani, et al.
Published: (2024)

Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery
by: Abdulaziz L, et al.
Published: (2022)

Investigation renin inhibitor activity from flavonoids derivates by in silico study
by: Aprilita Rina Yanti Eff, et al.
Published: (2023)